paclitaxel has been researched along with Renal Insufficiency in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (10.71) | 18.2507 |
| 2000's | 12 (42.86) | 29.6817 |
| 2010's | 11 (39.29) | 24.3611 |
| 2020's | 2 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Kishimoto, J; Okamoto, I; Shimose, T; Shiraishi, Y; Sugawara, S; Toi, Y | 1 |
| Khan, SA; Parajuli, SB; Rayamajhi, A; Sah, S; Sapkota, S | 1 |
| Hirsh, V; Ko, A; Langer, CJ; Renschler, MF; Socinski, MA | 1 |
| Fang, J; Liu, LF; Wu, MJ; Yin, ZM; Yu, AJ; Yu, H; Zhu, JQ | 1 |
| Campbell, MT; Carolla, RL; Harris, DR; Munsell, MF; Pagliaro, LC; Siefker-Radtke, AO | 1 |
| Ann, SH; Chang, K; Chung, WS; Her, SH; Kim, DB; Kim, PJ; Koh, YS; Lee, JM; Park, CS; Park, HJ; Seo, SM; Seung, KB; Shin, DI | 1 |
| Aoki, J; Cambier, PA; Cannon, L; Dawkins, KD; Ellis, SG; Greenberg, J; Grube, E; Mandinov, L; Mann, JT; Mintz, GS; Stone, GW; Weissman, NJ; Yu, A | 1 |
| Aronow, WS; Kakar, P; Kalapatapu, K; Lal, P; Mohan, D; Monsen, CE; Palaniswamy, C; Pucillo, AL; Singh, T; Sorbera, C; Sukhija, R; Weiss, MB | 1 |
| Chae, SC; Cho, MC; Choi, DJ; Jeong, MH; Kim, CH; Kim, HS; Kim, KH; Koo, BK; Lee, SR; Min, HS; Park, BJ; Park, KW; Park, SK; Seong, IW | 1 |
| Hayashi, Y; Hirao, H; Kawase, T; Masaoka, Y; Mito, S; Motoda, C; Muraoka, Y; Okimoto, T; Otsuka, M; Takeda, R; Tamekiyo, H; Toyofuku, M; Ueda, H; Watanabe, N | 1 |
| Arashi, H; Hagiwara, N; Higashitani, M; Hoshi, H; Kojika, A; Minami, Y; Mori, F; Ogawa, H; Takagi, A; Yamada, N; Yamaguchi, J; Yamauchi, T | 1 |
| Boersma, E; Magro, M; Nauta, S; Onuma, Y; Serruys, P; Simsek, C; Valstar, G; van der Giessen, W; van Domburg, R; van Geuns, RJ | 1 |
| Hamazaki, Y; Hosokawa, S; Kobayashi, Y; Kondo, S; Mutou, M; Nishikura, T; Nishimura, H; Sakurai, M; Tsujita, H; Tsukamoto, S; Yokota, H | 1 |
| Almalla, M; Hoffmann, R; Marx, N; Pross, V; Schröder, JW | 1 |
| Ito, K; Koizumi, T; Niikura, H; Okamura, K; Yaegashi, N | 1 |
| Akedo, I; Kubo, M; Mori, M; Nakagawa, C; Nishida, Y; Ono, H; Sakai, K; Takeda, E; Tamura, K; Tsugawa, M; Yanagi, K | 1 |
| Inui, K; Jiko, M; Okuda, M; Yano, I | 1 |
| Dewan, P; Lin, DW; Montgomery, RB; Wright, JL | 1 |
| Bui, A; Chu, WW; Clavijo, LC; Fournadjieva, J; Gevorkian, N; Kent, KM; Kim, SW; Kuchulakanti, PK; Ohlmann, P; Pichard, AD; Rha, SW; Satler, LF; Smith, K; Suddath, WO; Torguson, R; Waksman, R; Xue, Z | 1 |
| Chen, JW; Meng, QG; Tang, Y; Wang, ZR; Xie, D | 1 |
| Alberola, V; Albert, A; Campos, JM; Caranyana, V; Juan, O; Muñoz, J | 1 |
| Aurier, E; Benassi, A; Cremonesi, A; Grilli, R; Guastaroba, P; Magnavacchi, P; Manari, A; Maresta, A; Marzocchi, A; Percoco, G; Piovaccari, G; Saia, F; Varani, E | 1 |
| de Bruijn, P; Fieren, MW; Heijns, JB; Loos, WJ; van der Burg, ME; van der Gaast, A; van Gelder, T | 1 |
| Roth, BJ | 1 |
| Dreicer, R; Gustin, DM; See, WA; Williams, RD | 1 |
| Archer, PG; Jones, RB; Merouani, A; Schrier, RW; Shpall, EJ | 1 |
| Chang, YH; Chen, KK; Chen, PM; Chiou, TJ; Fan, FS; Hsieh, RK; Huang, WJ; Lin, AT; Liu, JH; Wang, WS; Yang, MH; Yen, CC | 1 |
| Stadler, WM | 1 |
2 review(s) available for paclitaxel and Renal Insufficiency
| Article | Year |
|---|---|
Ifosfamide in the treatment of bladder cancer.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Gallium; Humans; Ifosfamide; Multicenter Studies as Topic; Paclitaxel; Remission Induction; Renal Insufficiency; Urinary Bladder Neoplasms; Vinblastine | 1996 |
Gemcitabine doublets in advanced urothelial cancer.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Clinical Trials, Phase II as Topic; Deoxycytidine; Doxorubicin; Forecasting; Gemcitabine; Humans; Methotrexate; Neoplasm Metastasis; Neoplasm Staging; Paclitaxel; Prognosis; Renal Insufficiency; Survival Analysis; Trastuzumab; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2002 |
7 trial(s) available for paclitaxel and Renal Insufficiency
| Article | Year |
|---|---|
Phase II study of carboplatin/nab-paclitaxel/atezolizumab combination therapy for advanced nonsquamous non-small cell lung cancer patients with impaired renal function: RESTART trial.
Topics: Albumins; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Humans; Kidney; Lung Neoplasms; Paclitaxel; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Renal Insufficiency | 2022 |
Weekly nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: analysis of safety and efficacy in patients with renal impairment.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Renal Insufficiency; Survival Rate; Treatment Outcome; Young Adult | 2015 |
Front-line Treatment with Gemcitabine, Paclitaxel, and Doxorubicin for Patients With Unresectable or Metastatic Urothelial Cancer and Poor Renal Function: Final Results from a Phase II Study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Transitional Cell; Deoxycytidine; Doxorubicin; Drug Therapy, Combination; Female; Filgrastim; Gemcitabine; Granulocyte Colony-Stimulating Factor; Humans; Kidney; Male; Middle Aged; Paclitaxel; Polyethylene Glycols; Recombinant Proteins; Renal Insufficiency; Urologic Neoplasms | 2016 |
Impact of mild or moderate renal insufficiency on the intravascular ultrasonic analysis of chronic vascular response to paclitaxel-eluting and bare-metal stents (from the TAXUS IV, V, and VI trials).
Topics: Aged; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Circulation; Coronary Disease; Creatinine; Female; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Paclitaxel; Prospective Studies; Renal Insufficiency; Severity of Illness Index; Stents; Time Factors; Treatment Outcome; Tubulin Modulators; Ultrasonography, Interventional; Vascular Resistance | 2008 |
Measurement and impact of co-morbidity in elderly patients with advanced non-small cell lung cancer treated with chemotherapy. A phase II study of weekly paclitaxel.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Comorbidity; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Heart Diseases; Humans; Lung Neoplasms; Male; Multivariate Analysis; Paclitaxel; Patient Compliance; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Renal Insufficiency; Severity of Illness Index; Survival Analysis; Treatment Outcome; Vascular Diseases | 2007 |
Paclitaxel in advanced urothelial carcinoma: its role in patients with renal insufficiency and as salvage therapy.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Transitional Cell; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Renal Insufficiency; Salvage Therapy; Urinary Bladder Neoplasms; Urothelium | 1996 |
Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Bone Marrow Transplantation; Breast Neoplasms; Carmustine; Cisplatin; Creatinine; Cyclophosphamide; Dose-Response Relationship, Drug; Electrolytes; Female; Hematopoiesis; Humans; Kidney Function Tests; Neoplasm Metastasis; Neutropenia; Paclitaxel; Renal Insufficiency; Risk Factors; Transplantation, Autologous | 1996 |
19 other study(ies) available for paclitaxel and Renal Insufficiency
| Article | Year |
|---|---|
Promising Response of Paclitaxel in Metastatic Transitional Cell Carcinoma of Distal Ureter Complicated with Hydroureteronephrosis: A Case Report.
Topics: Aged; Carcinoma, Transitional Cell; Female; Humans; Hydronephrosis; Lung Neoplasms; Paclitaxel; Renal Insufficiency; Ureter; Ureteral Neoplasms | 2023 |
Effects and toxicity of neoadjuvant chemotherapy preoperative followed by adjuvant chemoradiation in small cell neurdendocrine cervical carcinoma.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Doxorubicin; Etoposide; Female; Hepatic Insufficiency; Humans; Hysterectomy; Ifosfamide; Middle Aged; Neoadjuvant Therapy; Neutropenia; Paclitaxel; Renal Insufficiency; Thrombocytopenia; Treatment Outcome; Uterine Cervical Neoplasms; Vincristine | 2015 |
Sirolimus-eluting stent is superior to paclitaxel-eluting stent for coronary intervention in patients with renal insufficiency: Long-term clinical outcomes.
Topics: Aged; Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Registries; Renal Insufficiency; Republic of Korea; Risk Factors; Sirolimus; Survival Rate; Time Factors | 2016 |
Major adverse cardiac events in patients with moderate to severe renal insufficiency treated with first-generation drug-eluting stents.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Renal Insufficiency; Retrospective Studies; Sirolimus | 2010 |
Comparison of drug-eluting versus bare-metal stent implantation in ST-elevation myocardial infarction patients with renal insufficiency: results from the national registry in Korea.
Topics: Aged; Drug-Eluting Stents; Female; Humans; Male; Myocardial Infarction; Paclitaxel; Prospective Studies; Prosthesis Design; Registries; Renal Insufficiency; Republic of Korea; Sirolimus; Stents; Treatment Outcome | 2012 |
Clinical usefulness of drug-eluting stents in the treatment of dialysis patients with coronary artery disease.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Hospital Mortality; Humans; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prosthesis Design; Renal Dialysis; Renal Insufficiency; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2011 |
Efficacy of paclitaxel-eluting stent implantation in hemodialysis patients.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Proportional Hazards Models; Prosthesis Design; Renal Dialysis; Renal Insufficiency; Retrospective Studies; Sirolimus; Time Factors; Treatment Outcome | 2011 |
Impact of renal insufficiency on safety and efficacy of drug-eluting stents compared to bare-metal stents at 6 years.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Biomarkers; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Creatinine; Drug-Eluting Stents; Female; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Kidney; Male; Metals; Middle Aged; Multivariate Analysis; Netherlands; Paclitaxel; Patient Safety; Proportional Hazards Models; Prosthesis Design; Registries; Renal Insufficiency; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Stents; Time Factors; Treatment Outcome | 2012 |
Sirolimus-eluting stents versus paclitaxel-eluting stents for coronary intervention in patients with renal failure on hemodialysis.
Topics: Aged; Aged, 80 and over; Coronary Angiography; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Renal Dialysis; Renal Insufficiency; Sirolimus; Treatment Outcome | 2013 |
Three-year follow-up after treatment of bare-metal stent restenosis with first-generation or second-generation drug-eluting stents.
Topics: Aged; Coronary Angiography; Coronary Restenosis; Coronary Thrombosis; Diabetes Mellitus; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Percutaneous Coronary Intervention; Renal Insufficiency; Retrospective Studies; Sirolimus; Stents | 2013 |
Carboplatin-based chemotherapy in patients with gynecological malignancies on long-term hemodialysis.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Endometrial Neoplasms; Female; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Renal Dialysis; Renal Insufficiency; Time Factors | 2003 |
[A case of non-small cell lung carcinoma successfully treated with carboplatin and weekly paclitaxel under renal dysfunction].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chronic Disease; Drug Administration Schedule; Humans; Lung Neoplasms; Male; Nephritis; Paclitaxel; Pleural Effusion, Malignant; Renal Insufficiency | 2004 |
Altered pharmacokinetics of paclitaxel in experimental hepatic or renal failure.
Topics: Animals; Carbon Tetrachloride; Cytochrome P-450 Enzyme System; Liver Failure; Male; Metabolic Clearance Rate; Microsomes, Liver; Paclitaxel; Rats; Rats, Wistar; Renal Insufficiency; Steroid Hydroxylases | 2005 |
Tumor lysis syndrome in a patient with metastatic, androgen independent prostate cancer.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Bone Marrow Neoplasms; Bone Neoplasms; Hematuria; Humans; Hydronephrosis; Liver Neoplasms; Male; Middle Aged; Paclitaxel; Prostate-Specific Antigen; Prostatic Neoplasms; Renal Dialysis; Renal Insufficiency; Tumor Lysis Syndrome | 2005 |
Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents.
Topics: Aged; Angiography; Case-Control Studies; Clopidogrel; Drug Delivery Systems; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Paclitaxel; Renal Insufficiency; Sirolimus; Stents; Thrombosis; Ticlopidine; Treatment Outcome | 2006 |
[A case report of paclitaxel combined with carboplatin for poorly differentiated prostate cancer with renal failure].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Humans; Male; Paclitaxel; Prostatic Neoplasms; Renal Dialysis; Renal Insufficiency | 2007 |
Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Diabetes Mellitus; Drug Implants; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Registries; Renal Insufficiency; Risk Factors; Sirolimus; Stents; Ticlopidine; Treatment Outcome | 2007 |
Continuous ambulatory peritoneal dialysis: pharmacokinetics and clinical outcome of paclitaxel and carboplatin treatment.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Peritoneal Dialysis, Continuous Ambulatory; Renal Insufficiency; Treatment Outcome | 2008 |
Single agent paclitaxel as a first-line therapy in advanced urothelial carcinoma: its efficacy and safety in patients even with pretreatment renal insufficiency.
Topics: Aged; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Carcinoma, Transitional Cell; Drug Administration Schedule; Drug Evaluation; Female; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Middle Aged; Paclitaxel; Renal Insufficiency; Survival Analysis; Urinary Bladder Neoplasms | 2000 |